Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04886128 · ClinicalTrials.gov registry record
Improving Diagnostic Accuracy for Acute Heart Failure
A clinical trial of Dyspnea and Acute Heart Failure, sponsored by Vanderbilt University Medical Center.
- Active
- Registry status
- 2,800
- Enrollment target
- 1
- Study location
NCT04886128 is a study of Dyspnea and Acute Heart Failure that is active but no longer recruiting, run by Vanderbilt University Medical Center. The registered enrollment target is 2,800 participants, above the 184-participant average among 23 other Dyspnea trials with a reported enrollment target (1422% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04886128, a study of Dyspnea and Acute Heart Failure, is active but no longer recruiting, sponsored by Vanderbilt University Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- 2,800 participants
- Enrollment target
- 1
- Study location
Study Summary
Acute heart failure is a common reason for emergency department visits and hospitalization, but the diagnosis can be challenging because of non-specific symptoms and signs. The current diagnostic approach to acute heart failure has modest accuracy, leading to delayed diagnosis and treatment, which associate with worse prognosis. Prior work suggests diagnostic accuracy can be improved with the addition of multiple circulating biomarkers discovered through proteomics, and this study will derive and validate a multi-marker model to improve diagnostic accuracy for acute heart failure in the emergency department.
Conditions Studied
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,800 participants |
| Start Date | 2021-08-31 |
| Est. Completion | 2026-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04886128
The ClinicalTrials.gov registry entry for NCT04886128 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 2,800 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 184-participant average among 23 other Dyspnea trials with a reported enrollment target (1422% higher). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Dyspnea appearing as the primary indexed condition, and to 0 interventions.
NCT04886128 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT04886128 about?
NCT04886128 is a clinical study titled "Improving Diagnostic Accuracy for Acute Heart Failure". Acute heart failure is a common reason for emergency department visits and hospitalization, but the diagnosis can be challenging because of non-specific symptoms and signs. The current diagnostic approach to acute heart failure has modest accuracy, leading to delayed diagnosis and treatment, which a...
What is the current status of trial NCT04886128?
This trial is currently active not recruiting. The enrollment target is 2,800 participants. The study started on 2021-08-31. Estimated completion is 2026-06-30.
What conditions does trial NCT04886128 study?
This clinical trial studies the following conditions: Dyspnea, Acute Heart Failure, Dyspnea; Cardiac.
Who is sponsoring clinical trial NCT04886128?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04886128 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dyspnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
129Xe MRI Cardiopulmonary
RECRUITING · Phase 2
-
Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology
RECRUITING · Phase 2
-
The Increase of Lung Capacity Using the Lung Master (Pulmonary Exerciser)
RECRUITING · NA
-
Ventilatory and Perfusion Abnormalities in Individuals With Post-Acute Sequelae of SARS-CoV-2 Infection
RECRUITING
-
Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
RECRUITING · Phase 2
-
Inspiratory Muscle Training for Breast Cancer Patients on Chemotherapy
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.